Advertisement

InSite Vision narrowly wins affirmation of a patent infringement win against the University of California, San Francisco, in a battle over eye infection treatment.

InSite Vision logo

InSite Vision (OTC:INSV) eked out a narrow win against the University of California in San Francisco in a patent battle over eye treatment.

Alameda, Calif.-based InSite touted a split U.S. Court Federal Circuit Court of Appeals decision in its favor, upholding the U.S. Patent & Trademark Office's panel ruling that the InSite is the true owner of a pair of patents pertaining to the AzaSite line of bacterial eye infection medication.

Advertisement
Advertisement